Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.04% rose 1.75% to $176.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.30% rising 0.01% to 3,901.36 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.00% rising 0.03% to 31,261.90. The stock's rise snapped a two-day losing streak. Johnson & Johnson closed $9.71 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.92% rose 3.25% to $326.30, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -1.10% rose 1.59% to $93.55, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.61% rose 3.59% to $52.47. Trading volume (7.5 M) remained 139,558 below its 50-day average volume of 7.6 M.